naloxone
Research Roundup
Digoxin, opioids, yoga… Debbie Rigby takes a look at the latest in research news Digoxin and Mortality in Patients With Atrial Fibrillation In patients with AF taking digoxin, the risk …
Naloxone barriers identified
Two studies presented at this week’s drug and alcohol conference have examined the barriers to pharmacists providing naloxone Awareness and preparedness to supply were identified as two key barriers by …
Weekly Dose: Naloxone, how to save a life from opioid overdose
Weekly Dose: Naloxone, how to save a life from opioid overdose Suzanne Nielsen, UNSW Australia and Simon Lenton, Curtin University Naloxone is an opioid antagonist, used as an “antidote” for …
Pharmacists lack confidence in supplying naloxone
They feel the need for more training, but downscheduling champion Angelo Pricolo says this shouldn’t be an issue An online survey of nearly 600 Australian pharmacists run by the National …
PDL Practice Alert
Important changes to legislation regarding pseudoephedrine and naloxone On February 1, 2016, the scheduling on Naloxone changed from S4 to S3 for the treatment of opioid overdose. The two current …
‘If you pay peanuts, you get monkeys’ – the week’s best comments
AJP takes a look back at this week’s best reader comments Several readers responded to our report that the TGA has advised of a shortage of metformin extended release tablets: …